Optimized basal-bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: no favorable effects on glycemic control, physiological responses to hypoglycemia, well-being, or treatment satisfaction.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Diabetes Care

• Publication date

  2000-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/DIACARE.23.5.629PMID 10834421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes care

  2019cited by this paper
• Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

  1999cited by this paper
• Insulin analogues and their potential in the management of diabetes mellitus

  1999cited by this paper
• Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.

  1999cited by this paper
• Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM

  1998cited by this paper
• A comparison of the standard and the computerized versions of the Well-being Questionnaire (WBQ) and the Diabetes Treatment Satisfaction Questionnaire (DTSQ)

  1998cited by this paper
• Time-Action Profiles of Novel Premixed Preparations of Insulin Lispro and NPL Insulin

  1998cited by this paper
• Use of the short‐acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time‐interval injection‐meal

  1998cited by this paper
• Reduction of Postprandial Hyperglycemia and Frequency of Hypoglycemia in IDDM Patients on Insulin-Analog Treatment

  1997cited by this paper
• Nighttime Insulin Kinetics and Glycemic Control in Type 1 Diabetes Patients Following Administration of an Intermediate-Acting Lispro Preparation

  1997cited by this paper
• Counterregulatory Hormone Responses and Symptoms During Hypoglycaemia Induced by Porcine, Human Regular Insulin, and Lys(B28), Pro(B29) Human Insulin Analogue (Insulin Lispro) in Healthy Male Volunteers

  1997cited by this paper
• Health-Related Quality-of-Life Results From Multinational Clinical Trials of Insulin Lispro: Assessing benefits of a new diabetes therapy

  1997cited by this paper
• Pre‐meal Insulin Analogue Insulin Lispro vs Humulin® R Insulin Treatment in Young Subjects with Type 1 Diabetes

  1996cited by this paper
• Effects of the Short-Acting Insulin Analog [Lys(B28),Pro(B29)] on Postprandial Blood Glucose Control in IDDM

  1996cited by this paper
• Handbook of Psychology and Diabetes : A Guide to Psychological Measurement in Diabetes Research and Practice

  1994cited by this paper
• [Lys(B28), Pro(B29)]-Human Insulin: A Rapidly Absorbed Analogue of Human Insulin

  1994cited by this paper
• Hypoglycemia Unawareness in IDDM

  1993cited by this paper
• Hypoglycemia Unawareness in IDDM

  1993cited by this paper
• Serum Noradrenaline is Composed of Plasma and Platelet Noradrenaline

  1989cited by this paper
• Effects and Correlates of Blood Glucose Awareness Training Among Patients With IDDM

  1989cited by this paper
• Free and total insulin as determined after precipitation with polyethylene glycol: analytical characteristics and effects of sample handling and storage.

  1987cited by this paper

• Guía de práctica clínica sobre Diabetes Mellitus Tipo 1

  2026cites this paper
• Premix insulins in type 1 diabetes: the coming of degludec/aspart

  2019cites this paper
• The Impact of Hypoglycemia on the Cardiovascular System

  2016cites this paper
• Interventions That Restore Awareness of Hypoglycemia in Adults With Type 1 Diabetes: A Systematic Review and Meta-analysis

  2015cites this paper
• Potential for BIAsp70 to Control Postprandial Hyperglycemia in Children with Type 1 Diabetes Mellitus

  2014cites this paper
• An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK

  2009cites this paper
• Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes

  2007cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.

  2006cites this paper
• Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study.

  2006cites this paper
• Multiple mealtime administration of biphasic insulin aspart 30 versus traditional basal‐bolus human insulin treatment in patients with type 1 diabetes

  2006cites this paper
• Pharmacokinetic profiles of biphasic insulin aspart 30/70 and 70/30 in patients with Type 1 diabetes: a randomized double‐blinded crossover study

  2005cites this paper
• Use of the rapid acting insulin analogue lispro and its protamine retarded form (Humalog Mix 25) in a clinical setting

  2004cites this paper
• Measuring Treatment Satisfaction. A Review of Randomized Controlled Drug Trials

  2004cites this paper
• Subcutaneous insulin infusion in type 1 diabetes mellitus

  2003cites this paper
• Limitations to subcutaneous insulin administration in type 1 diabetes

  2003cites this paper
• Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial—mechanisms and implications

  2003cites this paper
• Insulin, glucagon, and hypoglycemic drugs

  2003cites this paper
• Basal‐bolus insulin therapy in Type 1 diabetes: comparative study of pre‐meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin

  2002cites this paper
• Insulin therapy: optimizing control in type 1 and type 2 diabetes.

  2001cites this paper
• Insulins today and beyond.

  2001cites this paper